Vitamin K2 Market Overivew, Trends, Growth Drivers, Opportunities, Industry Analysis, Top Companies, Regional Analysis, and Forecast – 2029
The global vitamin K2 market is on a trajectory of significant expansion, with an estimated value projected to reach USD 265 million by 2029 from 2024 valuation of USD 140 million, displaying a promising Compound Annual Growth Rate (CAGR) of 13.7%. As scientific research continues to highlight the benefits of Vitamin K2, particularly in calcium metabolism and the prevention of arterial calcification, more individuals are incorporating this nutrient into their diets. This heightened awareness is especially prevalent among the elderly. populations, who are at greater risk for osteoporosis and cardiovascular diseases, thereby fuelling demand for Vitamin K2 supplements.
Another significant contributor to market expansion is the rise of the health and wellness trend. Consumers worldwide are becoming more proactive about their health, seeking preventive measures to avoid chronic diseases. This shift is evident in the growing popularity of dietary supplements and functional foods fortified with essential nutrients like Vitamin K2. Moreover, advancements in the production and formulation of Vitamin K2 supplements are also playing a crucial role in the market’s upward trajectory. Innovations such as microencapsulation and improved delivery systems have enhanced the bioavailability and efficacy of Vitamin K2, making supplements more effective and appealing to consumers. These advancements not only improve the absorption of Vitamin K2 in the body but also extend the shelf life of products, ensuring that consumers receive the maximum benefits from their supplements.
Vitamin K2 Market Drivers: Growth in health consciousness among consumers and increasing health expenditure
The Vitamin K2 market is experiencing robust growth, primarily driven by the increasing health consciousness among consumers and the rise in health expenditure globally. As more individuals become aware of the importance of preventive healthcare, they are seeking out dietary supplements that can support their long-term well-being. This trend is evident across various demographics, from young adults focused on maintaining their health to older populations looking to manage age-related health issues. The growing emphasis on holistic health and wellness is leading consumers to invest in products that offer specific health benefits, such as improved bone density and cardiovascular health, which are directly linked to Vitamin K2. Additionally, higher disposable incomes and greater health expenditure are enabling consumers to spend more on premium health products, further boosting the demand for Vitamin K2 supplements.
Vitamin K2 Market Opportunities: Growing demand for natural and functional foods
The growing demand for natural and functional foods presents a significant opportunity for the Vitamin K2 market. Consumers are increasingly seeking out food products that not only provide essential nutrients but also offer additional health benefits. This trend towards functional foods is driven by a desire for more natural and holistic approaches to health and nutrition. Vitamin K2, known for its role in supporting bone and cardiovascular health, is a valuable ingredient in this market. Manufacturers are capitalizing on this opportunity by incorporating Vitamin K2 into a variety of food products, including dairy products, fermented foods, and nutritional bars. The preference for natural ingredients further enhances the appeal of Vitamin K2, as it can be sourced from natural origins such as fermented soybeans (natto) and certain cheeses. This growing demand for functional and natural foods is set to drive the expansion of the Vitamin K2 market.
Mk-7 Product Type is Witnessing Higher Growth During the Forecast Period.
Menaquinone-7 or MK-7 is the most studied menaquinone due to its high bioavailability, longer half-life, and more than three decades of clinical research. Furthermore, Vitamin K2 MK-7, specifically MenaQ7 and vitaMK7, represents a pivotal advancement in nutritional science, renowned for its dual benefits in bone and cardiovascular health. Distinct from its K1 counterpart, K2 MK-7’s superior bioavailability and extended half-life in the body make it optimal for promoting calcium utilization towards bone strength while preventing arterial calcification.
As consumer awareness grows and dietary deficiencies persist, the market potential for K2 MK-7 continues to expand, driven by increasing demand for scientifically validated supplements that address fundamental health challenges across diverse demographic segments.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80962397
Pharmaceuticals Emerge as the Second Dominant Application Segment in the Vitamin K2 Market.
The pharmaceutical sector is driven by its extensive therapeutic benefits and increasing incorporation into medical treatments. Vitamin K2’s importance in the pharmaceutical sector is underscored by its application in the prevention and treatment of osteoporosis, cardiovascular diseases, and certain types of cancer. As research continues to unveil the extensive health benefits of vitamin K2, its integration into pharmaceutical products is becoming increasingly prevalent.
Moreover, the potential anticancer properties of vitamin K2 are garnering attention within the pharmaceutical industry. Studies have suggested that vitamin K2 can induce apoptosis in cancer cells and inhibit their proliferation. According to an NCBI study, vitamin K2 induces differentiation and apoptosis in a wide array of human cancer cell lines. However, it is noteworthy that vitamin K2-mediated apoptosis proceeds much more slowly than the apoptosis induced by conventional anticancer agents. The inclusion of vitamin K2 in pharmaceutical products could, therefore, open new avenues for therapeutic interventions, providing patients with innovative treatment options.
Asia Pacific Is the Fastest-Growing Market for Vitamin K2 Among the Regions.
The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region’s rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.
Additionally, the robust growth of the e-commerce sector in the Asia Pacific (APAC) region has significantly facilitated easy access to a wide range of Vitamin K2 products, contributing to the market’s expansion. One of the main advantages is the proliferation of online retail platforms, such as Amazon, Alibaba, and other regional e-commerce giants. These platforms have not only increased the visibility of Vitamin K2 supplements but have also allowed for a broader distribution network, reaching consumers in even the most remote areas.
Top Companies in the Vitamin K2 Market
The key players in this market include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea).
Gnosis by Lesaffre (NattoPharma) (France)
Gnosis, a business unit of Lesaffre, has leveraged nearly 170 years of fermentation expertise to become a leader in the field. Founded in 2018 through the merger of Gnosis Advanced Biotech and Lesaffre Human Care, and further expanded with the acquisition of NattoPharma in 2021, Gnosis focuses on producing fermentation-derived ingredients for dietary supplements, pharmaceuticals, and functional foods. The company operates in five key areas: immune health, digestive health, mobility and joint health, reproductive and women’s health, and cognitive health. Lesaffre, with a diverse workforce of 11,000 employees across 96 nationalities, ensures quality and innovation through its global network of 63 application centers and state-of-the-art R&D facilities like the Fermentis Campus. The company is certified in ISO22000, Non-GMO, Halal, and Kosher.
In October 2022, Gnosis by Lesaffre has recently launched MenaQ7 Matrix at SupplySide West, strengthening its position as the leading supplier of Vitamin K2 as MK-7. MenaQ7 Matrix combines the premier MenaQ7 Vitamin K2 as MK-7 with the award-winning Matrix K2 enhanced protective technology. This proprietary technology protects menaquinone particles without the need for coatings, additives, or additional ingredients, addressing the complex stability issues related to moisture and mineral salts that often affect Vitamin K2 formulations.
Kappa Bioscience AS (Balchem Corp.) (US)
Since 2022, Kappa Bioscience has been part of Balchem Corporation, a US-based global leader in specialty ingredients focused on nutrition and health. Balchem, a public company, operates in human and animal nutrition and health. With a strong presence in over 70 countries and major subsidiaries like Albion International and SensoryEffects Inc., Balchem serves the food, beverage, pharmaceutical, and dietary supplement industries. Kappa Bioscience, a leading vitamin K2 producer from Norway, is part of Balchem’s human nutrition and health segment. It has a geographical presence in over 70 countries across six continents.
In March 2022, Kappa Bioscience established a “Blue Ribbon” Scientific and Medical Advisory Board composed of prominent scientists from various fields. The advisory board aims to deepen and expand the scientific understanding of Menaquinone 7 (MK-7) Vitamin K2 and its associated health benefits.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=80962397
About MarketsandMarkets™
MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/vitamin-k2-market-80962397.html
